FREMONT, Calif., Shockwave Medical, a pioneer in the treatment of calcified cardiovascular disease, today announced clearance from the U.S. Food and Drug Administration (FDA) of the Lithoplasty ® ...

ATLANTA, GA (May 19, 2022) – One year outcomes from the Disrupt PAD III Trial comparing intravascular lithotripsy (IVL) with a drug-coated balloon (DCB) to percutaneous transluminal angioplasty (PTA) ...

BEAUFORT, S.C., January 15, 2025--(BUSINESS WIRE)--A new report published by THE SAGE GROUP reviews recent calcium research and quantifies the number of CLI patients with calcified leg arteries.

The comparison of peripheral chronic total occlusions and coronary CTOs is like comparing apples to oranges. There are many factors that differentiate the two, and merely using the same techniques and ...

There has been a redistribution in the risk of arterial disease in type 1 and 2 diabetes. The risks of heart attack and stroke have decreased significantly, while complications in more peripheral ...

The FDA cleared Shockwave Medical’s angioplasty balloon that delivers ultrasound shockwaves to break up calcified plaques in patients with peripheral artery disease, the company announced Friday. It ...

ZyVersa is developing Inflammasome ASC Inhibitor IC 100 for numerous inflammatory diseases WESTON, Fla., June 20, 2023 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA, or “ZyVersa”), a ...

Please provide your email address to receive an email when new articles are posted on . An 83-year-old Haitian woman was referred to the endocrine clinic for a thyroid nodule. The nodule was detected ...